Finch Therapeutics Group, Inc.·4

Dec 21, 4:38 PM ET

Vittiglio Joseph 4

4 · Finch Therapeutics Group, Inc. · Filed Dec 21, 2021

Insider Transaction Report

Form 4
Period: 2021-12-20
Vittiglio Joseph
Chief Business & Legal Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2021-12-20+125,000125,000 total
    Exercise: $9.68Exp: 2031-12-19Common Stock (125,000 underlying)
Footnotes (1)
  • [F1]Twenty-five percent (25%) of the shares subject to the option vest on December 20, 2022, and the remaining shares subject to the option shall vest in thirty-six (36) equal monthly installments thereafter, subject to the Reporting Person continuing to provide service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION